Cargando…

Commentary: Beyond “TRIM” Benefits of β-Glucan by Blood Glucose and Lipid Balancing Potentials in Its Defense Against COVID-19

Detalles Bibliográficos
Autores principales:	Ikewaki, Nobunao, Dedeepiya, Vidyasagar Devaprasad, Iwasaki, Masaru, Abraham, Samuel J. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039283/ https://www.ncbi.nlm.nih.gov/pubmed/33854499 http://dx.doi.org/10.3389/fimmu.2021.620658

Ejemplares similares

Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2022)

Benefits of Gut Microbiota Reconstitution by Beta 1,3–1,6 Glucans in Subjects with Autism Spectrum Disorder and Other Neurodegenerative Diseases
por: Raghavan, Kadalraja, et al.
Publicado: (2023)

Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis
por: Preethy, Senthilkumar, et al.
Publicado: (2022)

Improvement of sleep and melatonin in children with autism spectrum disorder after β‐1,3/1,6‐glucan consumption: An open‐label prospective pilot clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2022)

Biological response modifier glucan through balancing of blood glucose may have a prophylactic potential in COVID-19 patients
por: Ikewaki, Nobunao, et al.
Publicado: (2020)

Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2023)

Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
por: Raghavan, Kadalraja, et al.
Publicado: (2023)

Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease
por: Preethy, Senthilkumar, et al.
Publicado: (2022)

Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2022)

Hepatoprotective Effects of Aureobasidium pullulans Derived β 1,3–1,6 Glucans in a Murine Model of Non-alcoholic Steatohepatitis
por: Ikewaki, Nobunao, et al.
Publicado: (2022)

Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders
por: Preethy, Senthilkumar, et al.
Publicado: (2022)

β-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19
por: Ikewaki, Nobunao, et al.
Publicado: (2021)

Beta 1,3-1,6 Glucans Produced by Two Novel Strains of Aureobasidium Pullulans Exert Immune and Metabolic Beneficial Effects in Healthy Middle-aged Japanese Men: Results of an Exploratory Randomized Control Study
por: Ikewaki, N., et al.
Publicado: (2023)

Potentials to alleviate coagulopathy and enhance microglial function of beta (β)- glucans, making them worth a clinical study for COVID-19's neurological sequalae
por: Raghavan, Kadalraja, et al.
Publicado: (2021)

Potential Effects of Nichi Glucan as a Food Supplement for Diabetes Mellitus and Hyperlipidemia: Preliminary Findings from the Study on Three Patients from India
por: Dedeepiya, Vidyasagar Devaprasad, et al.
Publicado: (2012)

Coagulopathy associated with COVID-19 – Perspectives & Preventive strategies using a biological response modifier Glucan
por: Ikewaki, Nobunao, et al.
Publicado: (2020)

Re-examination of therapeutic management of muscular dystrophies using a vascular smooth muscle-centered approach
por: Preethy, Senthilkumar, et al.
Publicado: (2023)

Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management
por: Ikewaki, Nobunao, et al.
Publicado: (2023)

Smallpox Still Haunts Scientists: Results of a Questionnaire-Based Inquiry on the Views of Health Care and Life Science Experts and Students on Preserving the Remaining Variola Virus Stocks
por: Srinivasan, Thangavelu, et al.
Publicado: (2013)

Epidemiology and Outcomes of HIN1 Pneumonia in ICU
por: Golagana, Vinya, et al.
Publicado: (2023)

Cell Based Autologous Immune Enhancement Therapy (AIET) after Radiotherapy in a Locally Advanced Carcinoma of the Cervix
por: Premkumar, Sumana, et al.
Publicado: (2013)

Metaniche session 2016: Tailor-made sensors for rapid Therapeutic Drug Monitoring—Interactions between Biomaterial Physicists, Chemical Engineers and Clinicians for successful translation of technologies in Healthcare
por: Yoshimi, Yasuo, et al.
Publicado: (2016)

Commentary: Trim the fat
por: MacGillivray, Thomas E., et al.
Publicado: (2021)

Qualitative Evaluation of α-Synuclein: A Critical Step in Unravelling the Complexities of Autism Spectrum Disorder
por: Preethy, Senthilkumar, et al.
Publicado: (2022)

Possible Ambiguity in Interpretation Between Immunoglobulin G4-Related Disease (IgG4-RD) and Sarcoidosis in a Post-COVID-19 Pandemic
por: Gurunathan, Rajesh, et al.
Publicado: (2023)

Acute encephalitis syndrome following scrub typhus infection
por: Kar, Ayan, et al.
Publicado: (2014)

Index of CD34+ Cells and Mononuclear Cells in the Bone Marrow of Spinal Cord Injury Patients of Different Age Groups: A Comparative Analysis
por: Dedeepiya, Vidyasagar Devaprasad, et al.
Publicado: (2012)

Autologous Immune Enhancement Therapy in Recurrent Ovarian Cancer with Metastases: A Case Report
por: Manjunath, Sadananda Rao, et al.
Publicado: (2012)

TRIM Proteins in Host Defense and Viral Pathogenesis
por: Giraldo, Maria I., et al.
Publicado: (2020)

Feasibility and Safety of Peripheral Intravenous Administration of Vasopressor Agents in Resource-limited Settings
por: Padmanaban, Ajay, et al.
Publicado: (2020)

Beta-Glucan in Foods and Health Benefits
por: Aoe, Seiichiro
Publicado: (2021)

Production and Characterization of a Human Monoclonal Antibody Recognizing a New Antigen Expressed on Some Lymphoid Cells
por: Ikewaki, Nobunao, et al.
Publicado: (1990)

Intrinsic Cellular Defenses (TRIMS) in Modulating Viral Infection and Immunity
por: García-Sastre, Adolfo, et al.
Publicado: (2016)

Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements
por: Rao, Kosagi-Sharaf, et al.
Publicado: (2020)

Immunomodulation of Fungal β-Glucan in Host Defense Signaling by Dectin-1
por: Batbayar, Sainkhuu, et al.
Publicado: (2012)

Commentary: In defense of the Hawthorne effect
por: Caldarone, Christopher A.
Publicado: (2021)

Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of Aureobasidium pullulans produced β-glucan
por: Preethy, Senthilkumar, et al.
Publicado: (2023)

Beta Glucan: Health Benefits in Obesity and Metabolic Syndrome
por: El Khoury, D., et al.
Publicado: (2012)

Beyond energy balance regulation: The underestimated role of adipose tissues in host defense against pathogens
por: Barthelemy, Johanna, et al.
Publicado: (2023)

Radiation Degradation of β-Glucan with a Potential for Reduction of Lipids and Glucose in the Blood of Mice
por: Long, Nguyen Thanh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_98mp87fftfv6gov53eidnukpq2